Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer: A PRISMA-compliant meta-analysis

BACKGROUND: Numerous studies have investigated the associations between RARβ2, DAPK, hMLH1, p14, and p15 promoter hypermethylation and clinical progression of patients with breast cancer, however the results remained uncertain due to the small sample size. Therefore, we performed a meta-analysis to...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Ming, Xiong, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320171/
https://www.ncbi.nlm.nih.gov/pubmed/30572486
http://dx.doi.org/10.1097/MD.0000000000013666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320171/
https://www.ncbi.nlm.nih.gov/pubmed/30572486
http://dx.doi.org/10.1097/MD.0000000000013666

Ejemplares similares